Biotech Breakthroughs

Results

53

5 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

53 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$535.27	5.5%	49.1%	US$11.9b	US$678.06	9.6	63.7%	n/a	Pharmaceuticals & Biotech
	INSM	US$132.57	34.2%	8.7%	US$29.4b	US$200.05	25.4	66.4%	n/a	Pharmaceuticals & Biotech
	PRAX	US$370.68	19.5%	664.9%	US$10.2b	US$623.68	7.7	71.3%	n/a	Pharmaceuticals & Biotech
	MRKR	US$1.12	-8.9%	-12.5%	US$19.2m	US$7.87	5.3	69.0%	n/a	Pharmaceuticals & Biotech
	ANAB	US$57.87	5.0%	187.8%	US$1.6b	US$87.09	7.4	48.1%	38.9%	Pharmaceuticals & Biotech
	ARDX	US$3.94	-21.4%	-29.6%	US$996.8m	US$13.00	2.2	61.6%	n/a	Pharmaceuticals & Biotech
	IONS	US$55.42	0.6%	33.8%	US$9.5b	US$89.33	10.5	67.9%	n/a	Pharmaceuticals & Biotech
	ZYME	US$24.32	6.7%	86.8%	US$1.7b	US$40.33	46.5	39.6%	n/a	Pharmaceuticals & Biotech
	MREO New	US$0.31	-5.2%	-81.6%	US$43.5m	US$1.99	1.7	4.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$3.93	-5.8%	-51.1%	US$223.0m	US$4.38	0.8	63.7%	n/a	Pharmaceuticals & Biotech
	FRMM	US$6.25	7.0%	-93.9%	US$83.2m	US$9.50	8.8	127.7%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.75	1.3%	-0.8%	US$165.3m	US$3.20	126.2	59.7%	n/a	Pharmaceuticals & Biotech
	ALDX New	US$1.51	-2.6%	-71.8%	US$91.1m	US$6.60	2.4	61.9%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.12	0%	10.9%	US$285.8m	US$5.50	21.7	76.8%	n/a	Pharmaceuticals & Biotech
	RVMD New	US$205.55	6.2%	483.0%	US$44.4b	US$221.81	16.9	61.6%	n/a	Pharmaceuticals & Biotech
	RNXT	US$1.15	10.6%	4.5%	US$52.3m	US$7.03	34.8	73.0%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.69	-6.7%	1.7%	US$23.3m	US$7.15	18.0	55.5%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.54	11.9%	18.1%	US$226.7m	US$8.59	11.7	45.3%	n/a	Pharmaceuticals & Biotech
	VRDN	US$22.97	10.2%	27.8%	US$2.6b	US$36.63	36.6	63.1%	n/a	Pharmaceuticals & Biotech
	CTOR	US$0.73	10.6%	-56.8%	US$68.6m	US$4.00	12.1	60.0%	n/a	Pharmaceuticals & Biotech
	CGON	US$77.03	7.9%	208.7%	US$6.8b	US$91.08	1096.3	63.3%	n/a	Pharmaceuticals & Biotech
	HUMA	US$0.71	-0.3%	-60.4%	US$200.7m	US$2.05	95.0	60.9%	n/a	Pharmaceuticals & Biotech
	NAMS	US$27.62	0.3%	10.5%	US$3.3b	US$51.44	463.6	65.3%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.32	1.5%	1.5%	US$65.0m	US$9.00	108.9	66.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 2